Refine
Has Fulltext
- yes (9)
Is part of the Bibliography
- yes (9)
Document Type
- Journal article (9)
Language
- English (9)
Keywords
- 1st-line treatment (1)
- 3D lung tumor tissue models (1)
- 3D tissue models (1)
- 5-Fluorouracil (1)
- BRAF mutation (1)
- Beta-catenin (1)
- CCR2 (1)
- CCR4 (1)
- Carcinoma cells (1)
- EMT (1)
- Fibroblasts (1)
- Fluorouracil (1)
- Invasion (1)
- KRAS biomarker signatures (1)
- Matrix (1)
- Multicenter randomized-trial (1)
- NK cells (1)
- Tissue (1)
- adenocarcinoma of the lung (1)
- air-liquid interface (1)
- artificial membrane-permeability (1)
- asthmatic bronchial epithelium (1)
- bioinformatics (1)
- biomarker (1)
- bioreactor culture (1)
- boolean in silico models (1)
- cancer treatment (1)
- cellular signalling networks (1)
- chemokine receptor (1)
- collagens (1)
- colorectal cancer (1)
- combinatorial drug predictions (1)
- computer modelling (1)
- cytotoxicity (1)
- drug resistance (1)
- embryonic stem cells (1)
- epithelial cell culture (1)
- extracellular matrix (1)
- genetic engineering (1)
- immune cell infiltration (1)
- immunotherapies (1)
- immunotherapy (1)
- in silico simulation (1)
- in vitro models (1)
- invasion (1)
- invasiveness (1)
- lung and intrathoracic tumors (1)
- lung cancer (1)
- microRNAs (1)
- microRNA–target interaction (1)
- migration (1)
- modular tumor tissue models (1)
- on-a-chip (1)
- permeability (1)
- pulmonary drug-delivery (1)
- pulmonary imaging (1)
- reconstructed human epidermis (1)
- respiratory syncytial virus (1)
- secondary lung tumors (1)
- stemness (1)
- stratification (1)
- targeted combination therapy (1)
- targeted therapy (1)
- therapeutic strategy (1)
- trachea (1)
- trafficking (1)
- transport studies (1)
- vesicle-based barrier (1)
Institute
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (8)
- Theodor-Boveri-Institut für Biowissenschaften (5)
- Kinderklinik und Poliklinik (2)
- Comprehensive Cancer Center Mainfranken (1)
- Fakultät für Mathematik und Informatik (1)
- Frauenklinik und Poliklinik (1)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (1)
- Klinik und Poliklinik für Nuklearmedizin (1)
- Klinik und Poliklinik für Thorax-, Herz- u. Thorakale Gefäßchirurgie (1)
- Lehrstuhl für Orthopädie (1)
To improve and focus preclinical testing, we combine tumor models based on a decellularized tissue matrix with bioinformatics to stratify tumors according to stage-specific mutations that are linked to central cancer pathways. We generated tissue models with BRAF-mutant colorectal cancer (CRC) cells (HROC24 and HROC87) and compared treatment responses to two-dimensional (2D) cultures and xenografts. As the BRAF inhibitor vemurafenib is—in contrast to melanoma—not effective in CRC, we combined it with the EGFR inhibitor gefitinib. In general, our 3D models showed higher chemoresistance and in contrast to 2D a more active HGFR after gefitinib and combination-therapy. In xenograft models murine HGF could not activate the human HGFR, stressing the importance of the human microenvironment. In order to stratify patient groups for targeted treatment options in CRC, an in silico topology with different stages including mutations and changes in common signaling pathways was developed. We applied the established topology for in silico simulations to predict new therapeutic options for BRAF-mutated CRC patients in advanced stages. Our in silico tool connects genome information with a deeper understanding of tumor engines in clinically relevant signaling networks which goes beyond the consideration of single drivers to improve CRC patient stratification.